Rockefeller Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Rockefeller Capital Management's TAK Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Takeda Pharmaceutical (TAK) stake by 4.6% in Q3 2026, selling an estimated $14.3K and leaving 16,636 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #2428.
Rockefeller Capital Management first reported a position in TAK in Q1 2019 and has held it in 22 quarters since. The position peaked at $1.45M in Q1 2024. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Rockefeller Capital Management held 16,636 shares of Takeda Pharmaceutical worth $303K as of Q3 2026.
- Rockefeller Capital Management sold 805 Takeda Pharmaceutical shares in Q3 2026, an estimated $14.3K.
- Takeda Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2428 holding.
- Rockefeller Capital Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 22 quarters since.
- Rockefeller Capital Management's Takeda Pharmaceutical position peaked at $1.45M in Q1 2024.
- 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.